Matrix type influences embedded patient-derived osteosarcoma organoid invasion and response to treatment.
Saved in:
| Title: | Matrix type influences embedded patient-derived osteosarcoma organoid invasion and response to treatment. |
|---|---|
| Authors: | Hipwood L; Faculty of Health, School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, Australia.; Centre for Biomedical Technologies, Queensland University of Technology, Brisbane, QLD, Australia.; Gelomics Pty Ltd., Brisbane, QLD, Australia.; Translational Research Institute (TRI), Brisbane, QLD, Australia.; Max Planck Queensland Centre (MPQC) for the Materials Science of Extracellular Matrices, Queensland University of Technology, Brisbane, Australia., Vargas Reyes DM; Gelomics Pty Ltd., Brisbane, QLD, Australia.; The University of Queensland, Brisbane, QLD, Australia., Thompson EW; Faculty of Health, School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, Australia.; Translational Research Institute (TRI), Brisbane, QLD, Australia.; Centre for Genomics and Personalised Health, QUT, Brisbane, QLD, Australia., Rowell PD; Orthopaedics Department, Princess Alexandra Hospital, Metro South Hospital and Health Services, Brisbane, QLD, Australia., Lowe M; Orthopaedics Department, Princess Alexandra Hospital, Metro South Hospital and Health Services, Brisbane, QLD, Australia., Nicholls W; Oncology Services Group, Children's Health Queensland Hospital and Health Servies, Queensland Children's Hospital, Brisbane, QLD, Australia., Bhatia S; Faculty of Health, School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, Australia.; Centre for Biomedical Technologies, Queensland University of Technology, Brisbane, QLD, Australia.; Translational Research Institute (TRI), Brisbane, QLD, Australia., Hutmacher DW; Gelomics Pty Ltd., Brisbane, QLD, Australia.; Max Planck Queensland Centre (MPQC) for the Materials Science of Extracellular Matrices, Queensland University of Technology, Brisbane, Australia., Meinert C; Gelomics Pty Ltd., Brisbane, QLD, Australia., McGovern JA; Faculty of Health, School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, Australia.; Centre for Biomedical Technologies, Queensland University of Technology, Brisbane, QLD, Australia.; Translational Research Institute (TRI), Brisbane, QLD, Australia.; Max Planck Queensland Centre (MPQC) for the Materials Science of Extracellular Matrices, Queensland University of Technology, Brisbane, Australia. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2026 Jun 02; Vol. 17, pp. 1831729. Date of Electronic Publication: 2026 Jun 02 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1663-9812 |
|---|---|
| DOI: | 10.3389/fphar.2026.1831729 |
